Treatment of pretibial myxedema (PTM) with topical steroid ointment application with sealing cover (Steroid occlusive dressing technique: Steroid ODT) in Graves' patients

Internal Medicine

Volumn 49, Issue 7, 2010, Pages 665-669

  Takasu, Nobuyuki ^a   Higa, Haruyo ^a   Kinjou, Yoshino ^a  

^a Center of Endocrinology and Metabolism   (Japan)

Author keywords

Graves' disease; ODT; Pretibial myxedema (PTM); TBII; Topical steroid; TSAb; TSH receptor Ab (TRab)

Indexed keywords

GLYCOSAMINOGLYCAN; IODINE 131; MUCIN; PROPYLTHIOURACIL; STEROID; THIAMAZOLE; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; TRIAMCINOLONE ACETONIDE; OINTMENT;

ADULT; ARTICLE; CASE REPORT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GOITER; GRAVES DISEASE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; LIVER INJURY; MALE; MYXEDEMA; OCCLUSIVE DRESSING; OINTMENT; PRETIBIAL MYXEDEMA; SKIN BIOPSY; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT DURATION; COMPLICATION; LEG DERMATOSES; MIDDLE AGED; PATHOLOGY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; GRAVES DISEASE; HUMANS; LEG DERMATOSES; MALE; MIDDLE AGED; MYXEDEMA; OCCLUSIVE DRESSINGS; OINTMENTS; STEROIDS; TREATMENT OUTCOME;

EID: 77950585120     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2617     Document Type: Article

References (14)

1. Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 16: 409-415, 1987.
2. Fatourechi V, Pajouhi M, Fransway AF. Dermopathy of Graves' disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore) 73: 1-7, 1994.
3. Fatourechi V. Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol 6: 295-309, 2005.
4. Takasu N, Kamijo K, Sato Y, et al. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Clin Exp Pharmacol Physiol 31: 314-319, 2004.
5. Chang TC, Wu SL, Hsiao YL, et al. TSH and TSH receptor antibody-binding sites in fibroblasts of pretibial myxedema are related to the extracellular domain of entire TSH receptor. Clin Immunol Immunopathol 71: 113-120, 1994.
6. Stadlmayr W, Spitzweg C, Bichlmair AM, et al. TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid 7: 3-12, 1997.
7. Rapoport B, Alsabeh R, Aftergood D, et al. Elephantiasic pretibial myxedema: insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease. Thyroid 10: 685-692, 2000.
8. Daumerie C, Ludgate M, Costagliola S, et al. Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy. Eur J Endocrinol 146: 35-38, 2002.
9. Takasu N, Oshiro C, Akamine H, et al. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. J Endocrinol Invest 20: 452-461, 1997.
10. Kriss JP, Pleshakov V, Rosenblum A, et al. Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab 27: 595-604, 1967.
11. Frisch DR, Roth I. Pretibial myxedema. A review of the literature and case report. J Am Podiatr Med Assoc 75: 147-152, 1985.
12. Lang PG, Sisson JC, Lynch PJ. Intralesional triamcinolone therapy for pretibial myxedema. Arch Dermatol 111: 197-202, 1975.
13. Schwartz KM, Fatourechi V, Ahmed DD, et al. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 87: 438-446, 2002.
14. Heufelder AE, Dutton CM, Sarkar G, et al. Detection of TSH receptor RNA in cultured fibroblasts from patients with Graves' ophthalmopathy and pretibial dermopathy. Thyroid 3: 297-300, 1993.